Hem › Bronkcancer › Ohio
Kliniska studier för Bronkcancer i Ohio
6 studier för Bronkcancer söker deltagare vid platser i Ohio.
Städer i Ohio
Officiell studietext (engelska)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Miami Valley Hospital South, Centerville
- USO - Oncology Hematology Care, Cincinnati
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06119581Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Ohio State University Hospitals, Columbus
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 1 sep. 2026 · NCT07185997Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- University of Cincinnati Medical Center, Cincinnati
- Ohio State University Comprehensive Cancer Center, Columbus
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 26 juni 2026 · NCT04614103A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- University of Cincinnati, Cincinnati
RekryterarFas 1/2
Ålder 18 till 70 · Alla kön · Uppdaterad 11 juni 2026 · NCT05361174A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- The Ohio State University Wexner Medical Center, Columbus
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 27 maj 2026 · NCT03093116Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 19 feb. 2026 · NCT02984761Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.